Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Nigeria has been on the rise in recent years.
Customer preferences: Customers in Nigeria are becoming more aware of the importance of skincare and are willing to invest in products that can help them achieve healthy and glowing skin. This has led to an increase in demand for dermatological drugs, which are seen as effective in treating various skin conditions.
Trends in the market: One major trend in the dermatological drugs market in Nigeria is the growing popularity of natural and organic products. Consumers are increasingly looking for products that are free from harmful chemicals and are made from natural ingredients. This has led to the emergence of several local brands that offer natural and organic skincare products.Another trend in the market is the increasing use of technology in skincare. Consumers are now able to access dermatological services online, which has made it easier for them to get expert advice and recommendations on skincare products. This has also led to the growth of e-commerce platforms that specialize in selling dermatological drugs and other skincare products.
Local special circumstances: Nigeria has a large youth population, with a significant percentage of the population under the age of 30. This demographic is particularly interested in skincare and is willing to spend money on products that can help them achieve healthy and youthful-looking skin. Additionally, Nigeria has a hot and humid climate, which can lead to various skin conditions such as acne, eczema, and fungal infections. This has further fueled the demand for dermatological drugs in the country.
Underlying macroeconomic factors: Nigeria is one of the largest economies in Africa and has experienced significant economic growth in recent years. This has led to an increase in disposable income and consumer spending, which has further boosted the demand for dermatological drugs. Additionally, the Nigerian government has made efforts to improve healthcare infrastructure and increase access to healthcare services, which has also contributed to the growth of the dermatological drugs market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
